Cargando…
Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
Sulfonylureas (SU) continue to be a vital therapeutic category of oral hypoglycemic agents (OHAs) for the management of type 2 diabetes mellitus (T2DM). Physicians consider modern SU (gliclazide and glimepiride) as “safe and smart” choices for T2DM management. The presence of multiple international...
Autores principales: | Das, Ashok Kumar, Saboo, Banshi, Chawla, Rajeev, Aravind, S. R., Rajput, Rajesh, Singh, Awadhesh K., Mukherjee, J. J., Jhingan, Ashok, Shah, Parag, Deshmukh, Vaishali, Kale, Shailaja, Jaggi, Shalini, Sridhar, G. R., Dhediya, Rajnish, Gaurav, Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113130/ https://www.ncbi.nlm.nih.gov/pubmed/37360324 http://dx.doi.org/10.1007/s13410-023-01192-6 |
Ejemplares similares
-
RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus
por: Kumar, Vasanth, et al.
Publicado: (2022) -
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
por: Chawla, Rajeev, et al.
Publicado: (2020) -
Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas
por: Al-Saleh, Yousef, et al.
Publicado: (2021) -
Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines
por: Mohan, Viswanathan, et al.
Publicado: (2022) -
Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)